TrialRheumatology (Oxford, England)2023

Extent of fibrosis and lung function decline in patients with systemic sclerosis and interstitial lung disease: data from the SENSCIS trial.

Christopher P Denton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.